Apyx Medical Statistics
Total Valuation
Apyx Medical has a market cap or net worth of $48.57 million. The enterprise value is $58.80 million.
Important Dates
The last earnings date was Thursday, March 13, 2025, before market open.
Earnings Date | Mar 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Apyx Medical has 37.79 million shares outstanding. The number of shares has increased by 2.66% in one year.
Current Share Class | 37.79M |
Shares Outstanding | 37.79M |
Shares Change (YoY) | +2.66% |
Shares Change (QoQ) | +10.31% |
Owned by Insiders (%) | 14.56% |
Owned by Institutions (%) | 25.34% |
Float | 29.12M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.01 |
Forward PS | 1.07 |
PB Ratio | 3.64 |
P/TBV Ratio | 3.64 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.22 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.26, with a Debt / Equity ratio of 2.70.
Current Ratio | 5.26 |
Quick Ratio | 4.41 |
Debt / Equity | 2.70 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -3.19 |
Financial Efficiency
Return on equity (ROE) is -114.21% and return on invested capital (ROIC) is -19.88%.
Return on Equity (ROE) | -114.21% |
Return on Assets (ROA) | -16.35% |
Return on Invested Capital (ROIC) | -19.88% |
Return on Capital Employed (ROCE) | -34.82% |
Revenue Per Employee | $218,645 |
Profits Per Employee | -$106,650 |
Employee Count | 220 |
Asset Turnover | 0.67 |
Inventory Turnover | 2.14 |
Taxes
In the past 12 months, Apyx Medical has paid $252,000 in taxes.
Income Tax | 252,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.74% in the last 52 weeks. The beta is 1.18, so Apyx Medical's price volatility has been higher than the market average.
Beta (5Y) | 1.18 |
52-Week Price Change | +0.74% |
50-Day Moving Average | 1.34 |
200-Day Moving Average | 1.35 |
Relative Strength Index (RSI) | 56.88 |
Average Volume (20 Days) | 51,995 |
Short Selling Information
The latest short interest is 125,316, so 0.33% of the outstanding shares have been sold short.
Short Interest | 125,316 |
Short Previous Month | 138,999 |
Short % of Shares Out | 0.33% |
Short % of Float | 0.43% |
Short Ratio (days to cover) | 2.97 |
Income Statement
In the last 12 months, Apyx Medical had revenue of $48.10 million and -$23.46 million in losses. Loss per share was -$0.66.
Revenue | 48.10M |
Gross Profit | 29.36M |
Operating Income | -18.85M |
Pretax Income | -28.50M |
Net Income | -23.46M |
EBITDA | -18.25M |
EBIT | -18.85M |
Loss Per Share | -$0.66 |
Full Income Statement Balance Sheet
The company has $31.74 million in cash and $38.76 million in debt, giving a net cash position of -$7.02 million or -$0.19 per share.
Cash & Cash Equivalents | 31.74M |
Total Debt | 38.76M |
Net Cash | -7.02M |
Net Cash Per Share | -$0.19 |
Equity (Book Value) | 14.34M |
Book Value Per Share | 0.38 |
Working Capital | 45.72M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$18.05 million and capital expenditures -$722,000, giving a free cash flow of -$18.77 million.
Operating Cash Flow | -18.05M |
Capital Expenditures | -722,000 |
Free Cash Flow | -18.77M |
FCF Per Share | -$0.50 |
Full Cash Flow Statement Margins
Gross margin is 61.04%, with operating and profit margins of -39.18% and -48.78%.
Gross Margin | 61.04% |
Operating Margin | -39.18% |
Pretax Margin | -48.45% |
Profit Margin | -48.78% |
EBITDA Margin | -37.93% |
EBIT Margin | -39.18% |
FCF Margin | n/a |